Clinical Trial Update: Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187 [Phase 1]

View source ↗

Summary

A Phase 1 trial update assessing the safety, tolerability, pharmacokinetics, food effect, and pharmacodynamics of single and multiple doses of P11187 in individ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• P11187

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Overweight, Diabetes Mellitus Type 2 in Obese | Phase 1 | Status: UNKNOWN